Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference The new mini-textbook by Kamps & Hoffmann PDF, 110 pages

Colorectal Neoplasms

Free Subscription 24.02.2020 1 Am J Surg 1 Ann Surg 1 Anticancer Res 4 BMC Cancer 2 Br J Cancer 2 Br J Surg 1 Cancer Lett 1 Dis Colon Rectum 6 Gastroenterology 4 Gastrointest Endosc 7 Int J Cancer 1 Int J Colorectal Dis 1 J Am Coll Surg 1 J Clin Oncol 2 Lancet Gastroenterol Hepatol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Surg

1. GACHABAYOV M, Zhang N, Bergamaschi R
   How not to deal with sigmoid cancer.
   Am J Surg. 2019;217:806.
   PubMed     Text format    
   
   

   
   Ann Surg

2. SABBAGH C, Manceau G, Mege D, Abdalla S, et al
   Is Adjuvant Chemotherapy Necessary for Obstructing Stage II Colon Cancer? Results From a Propensity Score Analysis of the French Surgical Association Database.
   Ann Surg. 2020 Feb 14. doi: 10.1097/SLA.0000000000003832.
   PubMed     Text format     Abstract available
   
   

   
   Anticancer Res

3. NAKAMOTO T, Hokuto D, Nomi T, Yoshikawa T, et al
   Characteristics of Five-year Survivors After Liver Resection for Colorectal Liver Metastases in Modern Chemotherapy.
   Anticancer Res. 2020;40:1107-1116.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

4. TANAKA T, Sato T, Nishiofuku H, Masada T, et al
   Selective TACE with irinotecan-loaded 40 mum microspheres and FOLFIRI for colorectal liver metastases: phase I dose escalation pharmacokinetic study.
   BMC Cancer. 2019;19:758.
   PubMed     Text format     Abstract available
   
   
5. XU R, Wang W, Zhu B, Lin X, et al
   Disease characteristics and treatment patterns of Chinese patients with metastatic colorectal cancer: a retrospective study using medical records from China.
   BMC Cancer. 2020;20:131.
   PubMed     Text format     Abstract available
   
   
6. MIELE E, Abballe L, Spinelli GP, Besharat ZM, et al
   BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors.
   BMC Cancer. 2020;20:129.
   PubMed     Text format     Abstract available
   
   
7. SHEN Y, Guan Y, Hummel JJ, Shyu CR, et al
   Immunogenomic pathways associated with cytotoxic lymphocyte infiltration and survival in colorectal cancer.
   BMC Cancer. 2020;20:124.
   PubMed     Text format     Abstract available
   
   

   
   Br J Cancer

8. MORIMOTO Y, Mizushima T, Wu X, Okuzaki D, et al
   miR-4711-5p regulates cancer stemness and cell cycle progression via KLF5, MDM2 and TFDP1 in colon cancer cells.
   Br J Cancer. 2020 Feb 18. pii: 10.1038/s41416-020-0758.
   PubMed     Text format     Abstract available
   
   
9. GUO F, De Brabander I, Francart J, Candeur M, et al
   Benefits of switching from guaiac-based faecal occult blood to faecal immunochemical testing: experience from the Wallonia-Brussels colorectal cancer screening programme.
   Br J Cancer. 2020 Feb 18. pii: 10.1038/s41416-020-0754.
   PubMed     Text format     Abstract available
   
   

   
   Br J Surg

10. ZABOROWSKI A, Stakelum A, Winter DC
    Author response to: Total neoadjuvant therapy in rectal cancer-improvement or overtreatment?
    Br J Surg. 2019;106:1558.
    PubMed     Text format    
    
    
11. MROCZKOWSKI P, Dziki L
    Total neoadjuvant therapy in rectal cancer - improvement or overtreatment?
    Br J Surg. 2019;106:1558.
    PubMed     Text format    
    
    

    
    Cancer Lett

12. GAO Q, Li XX, Xu YM, Zhang JZ, et al
    IRE1alpha-targeting Downregulates ABC Transporters and Overcomes Drug Resistance of Colon Cancer Cells.
    Cancer Lett. 2020 Feb 12. pii: S0304-3835(20)30069.
    PubMed     Text format     Abstract available
    
    

    
    Dis Colon Rectum

13. MORRIS AM
    Checklist Compliance and Long-term Outcomes.
    Dis Colon Rectum. 2020;63:1-2.
    PubMed     Text format    
    
    

    
    Gastroenterology

14. GUPTA S, Lieberman D, Anderson JC, Burke CA, et al
    Spotlight: US Multi-Society Task Force on Colorectal Cancer Recommendations for Follow-up After Colonoscopy and Polypectomy.
    Gastroenterology. 2020 Feb 13. pii: S0016-5085(20)30219.
    PubMed     Text format    
    
    
15. NGUYEN LH, Goel A, Chung DC
    Pathways of Colorectal Carcinogenesis.
    Gastroenterology. 2020;158:291-302.
    PubMed     Text format     Abstract available
    
    
16. FRIDMAN WH, Miller I, Sautes-Fridman C, Byrne AT, et al
    Therapeutic Targeting of the Colorectal Tumor Stroma.
    Gastroenterology. 2020;158:303-321.
    PubMed     Text format     Abstract available
    
    
17. LIEBERMAN D, Gupta S
    Does Colon Polyp Surveillance Improve Patient Outcomes?
    Gastroenterology. 2020;158:436-440.
    PubMed     Text format     Abstract available
    
    
18. STOFFEL EM, Murphy CC
    Epidemiology and Mechanisms of the Increasing Incidence of Colon and Rectal Cancers in Young Adults.
    Gastroenterology. 2020;158:341-353.
    PubMed     Text format     Abstract available
    
    
19. KALTENBACH T, Anderson JC, Burke CA, Dominitz JA, et al
    Spotlight: US Multi-Society Task Force on Colorectal Cancer Recommendations for Endoscopic Removal of Colorectal Lesions.
    Gastroenterology. 2020 Feb 12. pii: S0016-5085(20)30220.
    PubMed     Text format    
    
    

    
    Gastrointest Endosc

20. TURSE EP, Dailey FE, Bechtold ML
    Impact of moderate versus deep sedation on adenoma detection rate in index average-risk screening colonoscopies.
    Gastrointest Endosc. 2019;90:502-505.
    PubMed     Text format     Abstract available
    
    
21. MINAMIDE T, Shinmura K, Ikematsu H, Yano T, et al
    Early-stage primary signet ring cell carcinoma of the colon with magnifying endoscopic findings.
    Gastrointest Endosc. 2019;90:529-531.
    PubMed     Text format    
    
    
22. KALTENBACH T, Anderson JC, Burke CA, Dominitz JA, et al
    Endoscopic Removal of Colorectal Lesions-Recommendations by the US Multi-Society Task Force on Colorectal Cancer.
    Gastrointest Endosc. 2020 Feb 14. pii: S0016-5107(20)30055.
    PubMed     Text format    
    
    
23. ANDERSON JC, Rex DK, Robinson C, Butterly LF, et al
    Association of small versus diminutive adenomas and the risk for metachronous advanced adenomas: data from the New Hampshire Colonoscopy Registry.
    Gastrointest Endosc. 2019;90:495-501.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

24. WANG Q, Wang Y, Liu Y, Zhang C, et al
    U2-related proteins CHERP and SR140 contribute to colorectal tumorigenesis via alternative splicing regulation.
    Int J Cancer. 2019;145:2728-2739.
    PubMed     Text format     Abstract available
    
    
25. IIOKA H, Saito K, Sakaguchi M, Tachibana T, et al
    Crumbs3 is a critical factor that regulates invasion and metastasis of colon adenocarcinoma via the specific interaction with FGFR1.
    Int J Cancer. 2019;145:2740-2753.
    PubMed     Text format     Abstract available
    
    
26. PARDINI B, Corrado A, Paolicchi E, Cugliari G, et al
    DNA repair and cancer in colon and rectum: Novel players in genetic susceptibility.
    Int J Cancer. 2020;146:363-372.
    PubMed     Text format     Abstract available
    
    
27. LIU T, Song X, Khan S, Li Y, et al
    The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: An old story, yet mesmerizing.
    Int J Cancer. 2020;146:1780-1790.
    PubMed     Text format     Abstract available
    
    
28. ZANUTTO S, Ciniselli CM, Belfiore A, Lecchi M, et al
    Plasma miRNA-based signatures in CRC screening programs.
    Int J Cancer. 2020;146:1164-1173.
    PubMed     Text format     Abstract available
    
    
29. KOMOR MA, de Wit M, van den Berg J, Martens de Kemp SR, et al
    Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression.
    Int J Cancer. 2020;146:1979-1992.
    PubMed     Text format     Abstract available
    
    
30. MOHRMANN L, Zowada MK, Strakerjahn H, Siegl C, et al
    A Perivascular Niche in the Bone Marrow Hosts Quiescent and Proliferating Tumorigenic Colorectal Cancer Cells.
    Int J Cancer. 2020 Feb 19. doi: 10.1002/ijc.32933.
    PubMed     Text format     Abstract available
    
    

    
    Int J Colorectal Dis

31. ABDEL-RAHMAN O
    A real-world, population-based study of the outcomes of patients with metastatic colorectal cancer to the peritoneum treated with or without cytoreductive surgery.
    Int J Colorectal Dis. 2020 Feb 14. pii: 10.1007/s00384-020-03525.
    PubMed     Text format     Abstract available
    
    

    
    J Am Coll Surg

32. CHOW Z, Gan T, Chen Q, Huang B, et al
    Non-Adherence to Standard of Care for Locally Advanced Colon Cancer as a Contributory Factor for High Mortality Rates in Kentucky.
    J Am Coll Surg. 2020 Feb 13. pii: S1072-7515(20)30165.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Oncol

33. SALVADOR MU, Truelson MRF, Mason C, Souders B, et al
    Comprehensive Paired Tumor/Germline Testing for Lynch Syndrome: Bringing Resolution to the Diagnostic Process.
    J Clin Oncol. 2019;37:647-657.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Gastroenterol Hepatol

34. OLEN O, Erichsen R, Sachs MC, Pedersen L, et al
    Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study.
    Lancet Gastroenterol Hepatol. 2020 Feb 13. pii: S2468-1253(20)30005.
    PubMed     Text format     Abstract available
    
    
35. HOU JK
    Colorectal cancer in Crohn's disease: closing the gap.
    Lancet Gastroenterol Hepatol. 2020 Feb 13. pii: S2468-1253(20)30046.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: